TTM
$1.90B
YoY change
+27.7%
5Y CAGR
+15.8%
Peak year (2025)
$1.69B
Cumulative operating income
$13.11B
Operating Income history chart for ResMed (RMD) from 1993 to 2025
Latest: $1.69B
Operating Income growth chart for ResMed (RMD) from 1993 to 2025
Latest: +27.7%
Operating Income history table for ResMed (RMD) from 1993 to 2025
| 2025 | $1.69B | +27.7% | +$365.47M | ||
| 2024 | $1.32B | +16.6% | +$188.02M | ||
| 2023 | $1.13B | +13.2% | +$131.59M | ||
| 2022 | $1.00B | +10.7% | +$96.61M | ||
| 2021 | $903.68M | +11.6% | +$94.02M | ||
| 2020 | $809.66M | +39.8% | +$230.40M | ||
| 2019 | $579.26M | +6.9% | +$37.43M | ||
| 2018 | $541.83M | +27.3% | +$116.03M | ||
| 2017 | $425.80M | -0.7% | −$3.15M | ||
| 2016 | $428.95M | +4.8% | +$19.72M | ||
| 2015 | $409.24M | +1.0% | +$4.15M | ||
| 2014 | $405.09M | +14.2% | +$50.26M | ||
| 2013 | $354.82M | +20.5% | +$60.42M | ||
| 2012 | $294.41M | +10.3% | +$27.48M | ||
| 2011 | $266.92M | +11.0% | +$26.54M | ||
| 2010 | $240.38M | +26.3% | +$50.07M | ||
| 2009 | $190.31M | +33.1% | +$47.34M | ||
| 2008 | $142.97M | +58.6% | +$52.81M | ||
| 2007 | $90.16M | -31.3% | −$41.14M | ||
| 2006 | $131.30M | +34.9% | +$33.95M | ||
| 2005 | $97.35M | +14.0% | +$11.99M | ||
| 2004 | $85.36M | +26.9% | +$18.12M | ||
| 2003 | $67.24M | -231.4% | +$118.40M | ||
| 2002 | −$51.16M | -296.4% | −$77.20M | ||
| 2001 | $26.04M | -21.4% | −$7.10M | ||
| 2000 | $33.14M | +31.0% | +$7.84M | ||
| 1999 | $25.30M | +46.2% | +$8.00M | ||
| 1998 | $17.30M | +108.4% | +$9.00M | ||
| 1997 | $8.30M | +124.3% | +$4.60M | ||
| 1996 | $3.70M | +32.1% | +$900.00K | ||
| 1995 | $2.80M | +115.4% | +$1.50M | ||
| 1994 | $1.30M | +85.7% | +$600.00K | ||
| 1993 | $700.00K | — | — |
- 2025$1.69B+27.7%
- 2024$1.32B+16.6%
- 2023$1.13B+13.2%
- 2022$1.00B+10.7%
- 2021$903.68M+11.6%
- 2020$809.66M+39.8%
- 2019$579.26M+6.9%
- 2018$541.83M+27.3%
- 2017$425.80M-0.7%
- 2016$428.95M+4.8%
- 2015$409.24M+1.0%
- 2014$405.09M+14.2%
- 2013$354.82M+20.5%
- 2012$294.41M+10.3%
- 2011$266.92M+11.0%
- 2010$240.38M+26.3%
- 2009$190.31M+33.1%
- 2008$142.97M+58.6%
- 2007$90.16M-31.3%
- 2006$131.30M+34.9%
- 2005$97.35M+14.0%
- 2004$85.36M+26.9%
- 2003$67.24M-231.4%
- 2002−$51.16M-296.4%
- 2001$26.04M-21.4%
- 2000$33.14M+31.0%
- 1999$25.30M+46.2%
- 1998$17.30M+108.4%
- 1997$8.30M+124.3%
- 1996$3.70M+32.1%
- 1995$2.80M+115.4%
- 1994$1.30M+85.7%
- 1993$700.00K—
Operating Income values are taken from ResMed's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Income at ResMed (RMD)
According to ResMed's latest reported financial statements, the company's current operating income (TTM) is $1.90B. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual operating income for ResMed (RMD) came in at $1.69B – grew 27.7% year-over-year.
Looking at the 2020–2025 (5 years) stretch, ResMed operating income compounded at +15.8% per year, sustaining 8 straight years of year-over-year growth.
The highest annual operating income of $1.69B was reported in 2025. The lowest in the available history was −$51.16M in 2002.
ResMed Operating Income by Year
ResMed Operating Income 2025: $1.69B
ResMed posted operating income of $1.69B in 2025, grew 27.7% from 2024. This figure represents the highest annual value in the available history.
ResMed Operating Income 2024: $1.32B
In 2024, ResMed reported operating income of $1.32B, grew 16.6% from 2023.
ResMed Operating Income 2023: $1.13B
ResMed operating income in 2023 was $1.13B, grew 13.2% from 2022.
ResMed Operating Income 2022: $1.00B
2022's operating income for ResMed came in at $1.00B, grew 10.7% from 2021.
ResMed Operating Income 2021: $903.68M
ResMed operating income in 2021 was $903.68M.
See more financial history for ResMed (RMD).
Sector peers by Operating Income
Healthcare peers of ResMed (RMD), ranked by their latest operating income
| $29.70B | |
| $25.60B | |
| $23.49B | |
| $20.09B | |
| $19.90B | |
| $18.96B | |
| $13.74B | |
| $10.68B |
- $29.70B
- $25.60B
- $23.49B
- $20.09B
- $19.90B
- $18.96B
- $13.74B
- $10.68B
Frequently asked questions
ResMed (RMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation